Skip to main content
×
Home
    • Aa
    • Aa

Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy

  • M. AJELLI (a1), S. MERLER (a1), A. PUGLIESE (a2) and C. RIZZO (a3)
Summary
SUMMARY

We describe the real-time modelling analysis conducted in Italy during the early phases of the 2009 A/H1N1v influenza pandemic in order to estimate the impact of the pandemic and of the related mitigation measures implemented. Results are presented along with a comparison with epidemiological surveillance data which subsequently became available. Simulated epidemics were fitted to the estimated number of influenza-like syndromes collected within the Italian sentinel surveillance systems and showed good agreement with the timing of the observed epidemic. On the basis of the model predictions, we estimated the underreporting factor of the influenza surveillance system to be in the range 3·3–3·7 depending on the scenario considered. Model prediction suggested that the epidemic would peak in early November. These predictions have proved to be a valuable support for public health policy-makers in planning interventions for mitigating the spread of the pandemic.

Copyright
Corresponding author
*Author for correspondence: Dr M. Ajelli, Predictive Models for Biomedicine & Environment, Bruno Kessler Foundation, Via Sommarive 18, I-38123 Trento Povo, Italy. (Email: ajelli@fbk.eu)
References
Hide All
1.Merler S, Ajelli M. The role of population heterogeneity and human mobility in the spread of pandemic influenza. Proceedings of the Royal Society B: Biological Sciences 2010; 277: 557565.
2.Merler S, Ajelli M, Rizzo C. Age-prioritized use of antivirals during an influenza pandemic. BMC Infectious Diseases 2009; 9: 117.
3.Ciofi degli Atti ML, et al. Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. PLoS ONE 2008; 3: e1790.
4.Ferguson NM, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437: 209214.
5.Halloran ME, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences USA 2008; 105: 46394645.
6.Wu JT, et al. Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Medicine 2006; 3: e361.
7.Germann TC, et al. Mitigation strategies for pandemic influenza in the United States. Proceedings of the National Academy of Sciences USA 2006; 103: 59355940.
8.Davey WJ, et al. Effective, robust design of community mitigation for pandemic influenza: a sytematic examination of proposed US guidance. PLoS ONE 2008; 3: e2606.
9.Longini IM Jr., et al. Containing pandemic influenza at the source. Science 2005; 309: 10831087.
10.Ferguson NM, et al. Strategies for mitigating an influenza pandemic. Nature 2006; 442: 448452.
11.World Health Organization. New influenza A (H1N1) virus: global epidemiological situation, 26 June 2009. Weekly Epidemiological Record 2009; 84: 249257 (http://www.who.int/wer/2009/wer8426/en/index.html). Accessed 13 May 2010.
12.Rizzo C, et al. Enhanced epidemiological surveillance of influenza A(H1N1)v in Italy. Eurosurveillance 2009; 14: pii=19266.
13.World Health Organization. Changes in reporting requirements for pandemic (H1N1) 2009 virus infection (http://www.who.int/csr/disease/swineflu/notes/h1n1_surveillance_20090710/en/index.html). Accessed 13 May 2010.
14.Balcan D, et al. Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. BMC Medicine 2009; 7: 45.
15.Hayden FG, et al. Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza. Journal of the American Medical Association 1999; 282: 12401246.
16.World Health Organization. Guidance document: Pandemic influenza preparedness and response (http://www.who.int/csr/disease/influenza/pipguidance2009/en/index.html) Accessed 13 May 2010.
17.World Health Organization. Situation updates – pandemic (H1N1) 2009 (http://www.who.int/csr/disease/swineflu/updates/en/index.html) Accessed 13 May 2010.
18.Fraser C, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324: 15571561.
19.Cauchemez S, et al. Estimating the impact of school closure on influenza transmission from sentinel data. Nature 2008; 452: 750754.
20.Xing Z, Cardona C. Preexisting immunity to pandemic (H1N1) 2009. Emerging Infectious Diseases 2009; 15 (http://www.cdc.gov/EID/content/15/11/1847.htm) Accessed 13 May 2010.
21.Reichert T, et al. Does glycosylation as a modifier of original antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infectious Diseases 2010; 10: 5.
22.Chowell G, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. New England Journal of Medicine 2009; 361: 674679.
23.Yang Y, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009; 326: 729733.
24.Munayco C, et al. Epidemiological and transmissibility analysis of influenza A(H1N1)v in a southern hemisphere setting: Peru. Eurosurveillance 2009; 14: 19299.
25.Nishiura H, et al. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Eurosurveillance 2009; 14: 19227.
26.Boelle PY, Bernillon P, Desenclos J. A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March–April 2009. Eurosurveillance 2009; 14: 19205.
27.Singer AC, et al. Meeting report: risk assessment of Tamiflu use under pandemic conditions. Environmental Health Perspectives 2008; 116: 15631567.
28.Cauchemez S, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. New England Journal of Medicine 2009; 361: 26192627.
29.Ghani AC, et al. The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Currents: Influenza 2009; RRN1130.
30.Lunelli A, et al. Understanding the dynamics of seasonal influenza in Italy: an analysis of disease incidence and population susceptibility. Presented at the European Scientific Conference on Applied Infectious Disease Epidemiology, Stockholm, Sweden, 26–28 October 2009.
31.Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morbidity and Mortality Weekly Report 2009; 58: 521524.
32.Zimmer S, Burke D. Historical perspective-emergence of influenza A (H1N1) viruses. New England Journal of Medicine 2009; 361: 279285.
33.Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proceedings of the National Academy of Sciences USA 2009; 106: 32433248.
34.Shaman J, et al. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biology 2010; 8: e1000316.
35.Miller MA, et al. The signature features of influenza pandemics – implications for policy. New England Journal of Medicine 2009; 360: 25952598.
36.Rizzo C, et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969–2001. Emerging Infectious Diseases 2007; 13: 694699.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 3
Total number of PDF views: 7 *
Loading metrics...

Abstract views

Total abstract views: 118 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.